CG Oncology Inc.
CGON | NASDAQ
$78.25
+$3.63 (+4.86%)
At close: Sep 21, 2026, 4:00 PM ET
$78.25
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:56 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Revenue | 4.04M | 1.14M | 204K | 191K | 10.36M |
Cost of Revenue | 4.65M | 82.1M | 45.75M | 15K | 10K |
Gross Profit | -607K | -80.96M | -45.55M | 176K | 10.35M |
Operating Income | -190.77M | -114.67M | -55.45M | -35.25M | -12.61M |
Interest Income | 29.93M | 26.62M | 6.9M | n/a | n/a |
Pretax Income | -161M | -88.04M | -48.61M | -35.44M | -12.84M |
Net Income | -161M | -88.04M | -48.61M | -35.44M | -12.84M |
Selling & General & Admin | 73.53M | 33.7M | 9.9M | 6.39M | 4.64M |
Research & Development | 116.64M | 82.1M | 45.75M | 29.03M | 18.32M |
Other Expenses | n/a | -82.1M | -45.75M | n/a | n/a |
Operating Expenses | 190.17M | 33.7M | 9.9M | 35.42M | 22.95M |
Interest Expense | n/a | n/a | n/a | 1K | 451K |
Selling & Marketing Expenses | n/a | n/a | n/a | -15K | -10K |
Cost & Expenses | 194.81M | 115.81M | 55.65M | 35.44M | 22.96M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 77.3M | 62.5M | 66.64M | 66.64M | 66.64M |
Shares Outstanding (Diluted) | 77.3M | 62.5M | 66.64M | 66.64M | 66.64M |
EPS (Basic) | -2.08 | -1.41 | -1.02 | -0.66 | -0.28 |
EPS (Diluted) | -2.08 | -1.41 | -1.02 | -0.66 | -0.28 |
EBITDA | -159.55M | -88.01M | -48.59M | -35.43M | -12.38M |
EBIT | -161M | -88.04M | -48.61M | -35.44M | -12.39M |
Depreciation & Amortization | 1.45M | 32K | 17K | 15K | 10K |
Add to Watchlist
Select watchlists to add or remove CGON